Presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2020
Collaborator: Dermatology Center, GEM Resopso, University Sorbonne Paris Nord
Authors: Halioua B, Zetlaoui J, Astruc A, Lévy-Heidmann T, Testa D, Bombezin-Domino A, Radoszycki L
Patients with chronic medical conditions (CMC) require regular access to healthcare professionals and have to take long-term treatments. The coronavirus (COVID-19) may affect their clinical outcomes.